![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CollPlant Secures CE Mark for Vergenix Wound Filler
CollPlant Secures CE Mark for Vergenix Wound Filler
CollPlant — a company that uses plant-based rhCollagen technology to develop tissue repair products — has earned the CE Mark for Vergenix, smoothing the path for its distribution in Europe.
Vergenix is a flowable gel designed for treatment of chronic and acute wounds.
Vergenix FG is one of the world’s first medical devices consisting of a recombinant collagen derived from plants, according to Yehiel Tal, CEO of CollPlant. — Anisa Jibrell
Upcoming Events
-
11Jul
-
18Jul
-
21Oct